4basebio PLC (88Q.DE)
EUR 14.6
(0.0%)
EUR 14.6
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -8.05 Million GBP | -37.88% |
| 2022 | -5.84 Million GBP | -65.58% |
| 2021 | -3.52 Million GBP | -467.04% |
| 2020 | -622 Thousand GBP | -48.1% |
| 2019 | -420 Thousand GBP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -5.48 Million EUR | 0.0% |
| 2023 Q4 | -4.34 Million EUR | -13.71% |
| 2023 FY | -8.05 Million GBP | -37.88% |
| 2023 Q2 | -3.82 Million EUR | -35.68% |
| 2022 Q4 | -2.81 Million EUR | -4.96% |
| 2022 FY | -5.84 Million GBP | -65.58% |
| 2022 Q2 | -2.68 Million EUR | -52.34% |
| 2021 Q2 | -2.01 Million EUR | -330.02% |
| 2021 FY | -3.52 Million GBP | -467.04% |
| 2021 Q4 | -1.76 Million EUR | 12.44% |
| 2020 Q2 | -337.73 Thousand EUR | 0.0% |
| 2020 FY | -622 Thousand GBP | -48.1% |
| 2020 Q4 | -468.1 Thousand EUR | -38.6% |
| 2019 FY | -420 Thousand GBP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| BioNTech SE | 690.4 Million EUR | 101.166% |
| CureVac N.V. | -274.2 Million EUR | 97.064% |
| Biotest Aktiengesellschaft | 143.5 Million EUR | 105.611% |
| Biotest Aktiengesellschaft | 143.5 Million EUR | 105.611% |
| BRAIN Biotech AG | -6.71 Million EUR | -19.911% |
| Formycon AG | -369 Thousand EUR | -2082.114% |
| Heidelberg Pharma AG | -21.2 Million EUR | 62.036% |
| Medigene AG | -16.14 Million EUR | 50.139% |